Metraipolis › archive › dc_81b339da01fa
Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia — Europe PMC PMID:35171941
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/35171941
- DOI
- 10.1371/journal.pone.0263920
- License (as archived)
- CC0-1.0
- Archived
- 2026-10-31T09:29:45.061Z
- SHA-256 of the archived text
51bfed605304ed6eb304f5bb31de242e762d565033cfa473b522bbbfbfbbe2f2- Stable URL of this page
https://metraipolis.com/documento/dc_81b339da01fa
How to cite
Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia — Europe PMC PMID:35171941 — Europe PMC (en), https://europepmc.org/article/MED/35171941 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_81b339da01fa (Metraipolis archive dc_81b339da01fa, sha256 51bfed605304ed6eb304f5bb31de242e762d565033cfa473b522bbbfbfbbe2f2)
BibTeX
@misc{dc81b339da01fa,
title = {Cervical cancer screening and treatment, HIV infection, and age: Program implementation in seven regions of Namibia — Europe PMC PMID:35171941},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/35171941},
note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_81b339da01fa; sha256 51bfed605304ed6eb304f5bb31de242e762d565033cfa473b522bbbfbfbbe2f2},
year = {2026}
}Archived text
Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/35171941. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
The aim of this study was to assess differences in cervical cancer screening and treatment outcomes by HIV status in a routine programmatic setting with a high generalized HIV prevalence. Women living with HIV (WLHIV) are at heightened risk of developing cervical cancer and the World Health Organization recommends all WLHIV who are sexually active be screened, regardless of age. In 2018, Namibia's Ministry of Health and Social Services introduced a screen-and-treat approach using visual inspection with acetic acid (VIA) and ablative treatment with cryotherapy or thermocoagulation with a focus on screening HIV-positive women due to Namibia's 11.5% prevalence of HIV in women aged 15-49. Using program data from October 2018 to March 2020 from seven of the country's 14 regions, we calculated descriptive statistics and chi-square tests to test the statistical significance of differences in VIA-positivity, ineligibility for ablative treatment, treatment completion, and same day treatment completion by HIV status. Between October 2018 and March 2020, the program conducted 14,786 cervical cancer screenings. Among 8,150 women who received their first VIA screening, more WLHIV screened VIA-positive (17%) than HIV-negative women (15%). This difference was statistically significant (p = 0.02). Among 2,272 women who screened VIA-positive at any screening, 1,159 (82%) completed ablative treatment. This suggests ablative treatment is feasible and acceptable in resource-limited settings. WLHIV were also more likely to complete treatment than HIV-negative women (p<0.01). Differences in health seeking behavior of sub-populations as well as resource availability between service delivery points should be considered for further investigation. Going forward in order to strengthen program implementation and expand screening access and uptake further investigation is needed to determine cancer incidence by HIV status, age, and time since last screening to assess cases that are averted as well as potential rates of overtreatment. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera). Pubblicazione: PloS one, 2022 (prima pubblicazione 2022-02-16). Identificativi: PMID 35171941 · PMCID PMC8849510 · DOI 10.1371/journal.pone.0263920. Descrittori MeSH principali: Health Plan Implementation. Pagina: https://europepmc.org/article/MED/35171941 — https://doi.org/10.1371/journal.pone.0263920. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito). Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0. Letto il 2026-10-31T09:18:39.603Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.